{
  "id": 19206485,
  "title": "Weight-Loss Drugs May Help Sleep Apnea and Arthritis",
  "url": "https://urgent.news/2026/11/09/weight-loss-drugs-may-help-sleep-apnea-and-arthritis",
  "topic": "culture",
  "section": "Culture",
  "published": "2026-11-09T19:59:32.000Z",
  "source": {
    "name": "Time",
    "slug": "time",
    "url": "https://time.com/article/2026/11/09/glp-1-weight-loss-drugs-may-help-sleep-apnea-and-arthritis/"
  },
  "original_language": "en",
  "account": "New FDA-approved GLP-1 drug Foundayo, still primarily marketed for weight loss, has shown promise in reducing obstructive sleep apnea episodes in obese individuals. In clinical trials, study participants who took Foundayo experienced an average loss of 28 pounds, corresponding to 11% of their initial body weight, compared to placebo. Notably, those on the drug also reported a 44% decrease in overnight apnea events over a year, placing Foundayo on par with Zepbound for sleep apnea treatment. Additionally, Foundayo's effects extend to easing knee pain caused by osteoarthritis, with injectable retatrutide demonstrating a 50% reduction in knee pain and significant weight loss in obese patients with the condition. Researchers suggest that GLP-1 drugs like Foundayo and retatrutide may contribute to pain relief through anti-inflammatory mechanisms, in addition to weight loss effects.",
  "summary": "Eli Lilly reported results from new studies exploring the effects of its GLP-1 weight-loss drugs on sleep apnea and arthritis.",
  "key_points": [
    "Foundayo, a GLP-1 drug, helps reduce obstructive sleep apnea in obese individuals.",
    "Study participants lost an average of 28 pounds, 11% of initial body weight."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}